Fund manager profile · Public preview
Biovance Capital
About Biovance Capital
Biovance Capital is a venture capital company investing in disruptive, early-stage biopharma companies across Europe. The company focuses on seed and Series A rounds and works closely with entrepreneurs to build leading companies with transformative treatments for patients in need. Biovance Capital is backed by the European Investment Fund and other public and private investors.
Company and team snapshot: 2 November 2026. Directory registration data: 2 November 2026.
- Registered entity
- Biovance Capital Partners, Sociedade de Capital de Risco, S.A.
- Manager type
- Alternative Investment Fund Manager (AIFM)
- Headquarters
- Lisboa
- Share capital
- €125,000
- Registration date
- 23 February 2024
Meet the team
Ana Agostinho
Office Manager
André Albergaria
Principal
Explore the full team and professional profiles in Portugal Funds.
Manager at a glance
Fund range
Top-level funds, excluding compartments. Active is a registration status; open-ended is a fund structure. These categories overlap and do not establish subscription availability.
Latest annual financials
Financial figures, reference periods and source documents are reserved for database research. EBITDA means earnings before interest, tax, depreciation and amortisation. Company earnings are different from fund returns.
Explore financial information in Portugal Funds ↗Manager documents
1 document available
Explore documents linked to Biovance Capital in the Portugal Funds database.
Documents held in the database with an available file · snapshot 2 November 2026.
View manager documents in Portugal Funds ↗Funds associated with Biovance Capital
BIOVANCE CAPITAL FUND I - Fundo de Capital de Risco Fechado
Closed-ended · Active
Registration 2053
Feature values are reserved for database research. This preview does not confirm eligibility, US acceptance or account arrangements for this fund.
More information in the Portugal Funds database ↗